Table: Daito -2017/18 group results

Daito Pharmaceutical

13/07/2018 07:00

Jul 13 (Reuters)- 
          Daito Pharamaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2018    May 31, 2017   May 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales           39.88           37.98          40.80                 
               (+5.0 pct)      (+4.4 pct)     (+2.3 pct)               
  Operating        4.16            3.83           4.30                 
               (+8.6 pct)      (+7.8 pct)     (+3.3 pct)               
  Recurring        4.24            3.88           4.35                 
               (+9.4 pct)      (+4.4 pct)     (+2.5 pct)               
  Net
  Net              3.04            2.66           3.10                 
               (+14.5 pct)     (+3.5 pct)     (+1.9 pct)               
  EPS          243.08 yen      212.26 yen     247.72 yen               
  Ann Div       33.00 yen       33.00 yen      36.00 yen               
  -Q2 Div       15.00 yen       15.00 yen      18.00 yen               
  -Q4 Div       18.00 yen       18.00 yen      18.00 yen               
  
  NOTE - Daito Pharamaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T